Cargando…
A case of successful conversion from everolimus to surgical resection of a giant pancreatic neuroendocrine tumor
BACKGROUND: Although pancreatic neuroendocrine tumors generally have a far better prognosis relative to pancreatic cancer, the varied manifestations lead to treatment-related challenges. Everolimus therapy is generally recommended for patients with advanced pancreatic neuroendocrine tumors; however,...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519517/ https://www.ncbi.nlm.nih.gov/pubmed/28730577 http://dx.doi.org/10.1186/s40792-017-0361-8 |